A tumour-promoting function of CCR5 has also been established in preclinical models: CCR5 knockout mice have significantly smaller tumours than CCR5+/+ mice when inoculated with B16 melanoma cells, with an increased infiltration of CTLs and natural killer (NK) cells in tumours [61]. This evidence concerns the gene CCR5 and melanoma.